DiscGenics Inc., a Salt Lake City-based late-stage clinical biopharmaceutical company focused on degenerative diseases of the spine, has appointed Chad Falciani to its board of directors. Falciani is a healthcare entrepreneur, investor and business leader and is the founder and chairman of Curiteva, a medical technology company focused on transformative biomaterials, in-house manufacturing, and an innovative platform of orthopedic implants. During his career, Falciani has developed expertise across a range of industries, including banking, finance, medtech, biologics and aerospace. He has served on numerous corporate and advisory boards, and has led through mergers and acquisitions, capital formation, operational expansion and commercialization efforts.
